BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29121713)

  • 1. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study.
    Kang D; Cho J; Kim IR; Kim MK; Kim WS; Kim SJ
    Cancer Res Treat; 2018 Oct; 50(4):1051-1063. PubMed ID: 29121713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic literature review of health-related quality of life among aggressive non-Hodgkin lymphoma survivors.
    Lin VW; Blaylock B; Epstein J; Purdum A
    Curr Med Res Opin; 2018 Aug; 34(8):1529-1535. PubMed ID: 29741105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
    Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
    Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life.
    Kim SH; Lee S; Kim SH; Ok ON; Kim IR; Choi E; Kang YK; Kim SJ; Lee MH
    Psychooncology; 2017 Mar; 26(3):330-336. PubMed ID: 27073128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of fear of cancer recurrence on survival among lymphoma patients.
    Kim SJ; Kang D; Kim IR; Yoon SE; Kim WS; Butow PN; Guallar E; Cho J
    Psychooncology; 2020 Feb; 29(2):364-372. PubMed ID: 31654534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma.
    Blaes AH; Ma L; Zhang Y; Peterson BA
    Leuk Lymphoma; 2011 Nov; 52(11):2105-10. PubMed ID: 21740095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.
    Ehrhardt MJ; Mulrooney DA; Li C; Baassiri MJ; Bjornard K; Sandlund JT; Brinkman TM; Huang IC; Srivastava DK; Ness KK; Robison LL; Hudson MM; Krull KR
    Cancer; 2018 Jan; 124(2):417-425. PubMed ID: 28915338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma.
    Hu Y; Wu LH; Guan HJ; Wu SY; Liu LZ; Cai RQ; Xu YJ; Zhang YZ; Sun XF; Zhu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Sept 15; 23(9):882-888. PubMed ID: 34535201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey.
    Compaci G; Conte C; Oberic L; Ysebaert L; Laurent G; Despas F
    BMC Cancer; 2019 Dec; 19(1):1178. PubMed ID: 31795958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma.
    Beaven AW; Samsa G; Zimmerman S; Smith SK
    Cancer Invest; 2016 Jul; 34(6):279-85. PubMed ID: 27379565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
    Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
    Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.
    Cho J; Kang D; Kim IR; Kim WS; Ferrell B; Kim SJ
    Cancer Res Treat; 2018 Jan; 50(1):204-211. PubMed ID: 28361524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute, long-term or non-vincristine-induced peripheral neuropathy among non-Hodgkin lymphoma survivors: Symptoms, daily activities, functional status, and quality of life.
    Su YC; Lai YH; Hsieh ST; Teng CJ; Lee YH
    Eur J Oncol Nurs; 2024 Apr; 69():102540. PubMed ID: 38461728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
    Paunescu AC; Copie CB; Malak S; Gouill SL; Ribrag V; Bouabdallah K; Sibon D; Rumpold G; Preau M; Mounier N; Haioun C; Jardin F; Besson C
    Ann Hematol; 2022 Feb; 101(2):317-332. PubMed ID: 34617134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry.
    Vissers PA; Thong MS; Pouwer F; Zanders MM; Coebergh JW; van de Poll-Franse LV
    J Cancer Surviv; 2013 Dec; 7(4):602-13. PubMed ID: 23918453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma.
    Jensen RE; Arora NK; Bellizzi KM; Rowland JH; Hamilton AS; Aziz NM; Potosky AL
    Cancer; 2013 Feb; 119(3):672-80. PubMed ID: 22951588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
    Oerlemans S; Mols F; Nijziel MR; Lybeert M; van de Poll-Franse LV
    Ann Hematol; 2011 Sep; 90(9):993-1004. PubMed ID: 21670973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism.
    Kiserud CE; Seland M; Holte H; Fosså A; Fosså SD; Bollerslev J; Bjøro T; Loge JH
    Acta Oncol; 2015 Jan; 54(1):49-59. PubMed ID: 25140862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.